Showing results (731-740 of 780) with videos related to

Sort By:
Pageof 78
Mayo Clinic Proceedings|August 8, 2016
Thrombotic Microangiopathy Care Pathway: A Consensus Statement for the Mayo Clinic Complement Alternative Pathway-Thrombotic Microangiopathy (CAP-TMA) Disease-Oriented GroupRonald S Go, Jeffrey L Winters, Nelson Leung, et al.
The Journal of Allergy and Clinical Immunology|December 1, 2022
The diagnosis of severe combined immunodeficiency (SCID): The Primary Immune Deficiency Treatment Consortium (PIDTC) 2022 DefinitionsChristopher C Dvorak, Elie Haddad, Jennifer Heimall, et al.
Journal of Clinical Immunology|May 22, 2018
Correction to: Use of Genetic Testing for Primary Immunodeficiency PatientsJennifer R Heimall, David Hagin, Joud Hajjar, et al.
The Journal of Infectious Diseases|January 20, 2021
Lost in Translation: Lack of CD4 Expression due to a Novel Genetic DefectAndrea Lisco, Peying Ye, Chun-Shu Wong, et al.
Parkinsonism & Related Disorders|December 24, 2019
Acute readmission following deep brain stimulation surgery for Parkinson's disease: A nationwide analysisRuth B Schneider, Joohi Jimenez-Shahed, Danielle S Abraham, et al.
Annals of Internal Medicine|October 22, 2019
Management of Nonvariceal Upper Gastrointestinal Bleeding: Guideline Recommendations From the International Consensus GroupAlan N Barkun, Majid Almadi, Ernst J Kuipers, et al.
Plos Genetics|March 22, 2024
Canadian COVID-19 host genetics cohort replicates known severity associationsElika Garg, Paola Arguello-Pascualli, Olga Vishnyakova, et al.
The Journal of Allergy and Clinical Immunology|February 4, 2026
A clinically validated assay for rapid determination of type I and type II interferon activity in systemic inflammatory diseasesMichael T Lam, Amrita Basu, Kailey E Brodeur, et al.
Frontiers in Immunology|March 24, 2025
Multidisciplinary approach to treating complex immune dysregulation disorders: an adaptive model for institutional implementationLauren A Henderson, Roshini S Abraham, Aisha Ahmed, et al.
Blood|January 7, 2006
Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantationAngela Dispenzieri, Martha Q Lacy, Jerry A Katzmann, et al.
Pageof 78